or Try an Advanced Search...

    Technical Analysis for FHTX - Foghorn Therapeutics Inc.

    Grade Last Price % Change Price Change
    F 5.49 4.97% 0.26
    FHTX closed up 4.97 percent on Friday, April 26, 2024, on 36 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    Earnings due: May 8
    *** please verify all earnings dates ***
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Flat
    Historical FHTX trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup 0.00%
    Wide Bands Range Expansion 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Oversold Stochastic Weakness 0.00%
    Wide Bands Range Expansion 4.97%
    Up 3 Days in a Row Strength 4.97%
    Gapped Down Weakness 4.97%
    Oversold Stochastic Weakness 4.97%
    Wide Bands Range Expansion 5.37%
    Older End-of-Day Signals for FHTX ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 8 hours ago
    Rose Above Previous Day's High about 10 hours ago
    Up 5% about 10 hours ago
    Up 3% about 10 hours ago
    Up 2% about 10 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    FHTX Chart by TradingView
    Basic chart:

    Profile

    Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control™ platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology and expects to file an IND for its first program later this year.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Life Sciences Biology Medication

    Is FHTX a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 16 Foghorn Therapeutics appoints Kristian Humer as chief financial officer
    Apr 16 Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Kristian Humer as Chief Financial Officer
    Apr 9 Foghorn Therapeutics Presents New Preclinical Data on Potential First-in-Class BRM Selective Inhibitor FHD-909 and Selective CBP and Selective EP300 Degrader Oncology Programs
    Apr 9 Foghorn Therapeutics (NASDAQ:FHTX) Is In A Good Position To Deliver On Growth Plans
    Apr 5 Foghorn Therapeutics to Participate in Needham’s 23rd Annual Virtual Healthcare Conference
    Apr 2 Does Foghorn Therapeutics (FHTX) Have the Potential to Rally 105.75% as Wall Street Analysts Expect?
    Mar 26 Foghorn to Host Conference Call and Webcast on Pipeline of Potential First-in-Class Medicines in Conjunction with the 2024 AACR Annual Meeting
    Mar 13 Foghorn Therapeutics Inc. (FHTX) Upgraded to Buy: Here's What You Should Know
    Mar 13 Wall Street Analysts Predict a 124.31% Upside in Foghorn Therapeutics Inc. (FHTX): Here's What You Should Know
    Mar 7 Foghorn Therapeutics Inc. (FHTX) Reports Q4 Loss, Tops Revenue Estimates
    See more FHTX news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.96
    52 Week Low 2.7
    Average Volume 99,555
    200-Day Moving Average 5.87
    50-Day Moving Average 6.51
    20-Day Moving Average 6.40
    10-Day Moving Average 5.52
    Average True Range 0.63
    RSI (14) 41.52
    ADX 16.23
    +DI 20.34
    -DI 24.23
    Chandelier Exit (Long, 3 ATRs) 6.16
    Chandelier Exit (Short, 3 ATRs) 6.69
    Upper Bollinger Bands 8.30
    Lower Bollinger Band 4.50
    Percent B (%b) 0.26
    BandWidth 59.33
    MACD Line -0.36
    MACD Signal Line -0.19
    MACD Histogram -0.1692
    Fundamentals Value
    Market Cap 231.77 Million
    Num Shares 42.2 Million
    EPS -2.46
    Price-to-Earnings (P/E) Ratio -2.23
    Price-to-Sales 8.40
    Price-to-Book 10.71
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 6.07
    Resistance 3 (R3) 6.02 5.78 5.97
    Resistance 2 (R2) 5.78 5.64 5.81 5.94
    Resistance 1 (R1) 5.64 5.55 5.71 5.68 5.91
    Pivot Point 5.40 5.40 5.44 5.42 5.40
    Support 1 (S1) 5.25 5.25 5.33 5.30 5.07
    Support 2 (S2) 5.01 5.16 5.04 5.04
    Support 3 (S3) 4.87 5.01 5.01
    Support 4 (S4) 4.91